School of Hospitality Administration, Zhejiang Yuexiu University, Shaoxing, China.
Center for International Education, Philippine Christian University, Manila, Philippines.
Front Public Health. 2023 Feb 9;11:1115650. doi: 10.3389/fpubh.2023.1115650. eCollection 2023.
This study conduct regressions of panal data with OLS and test with IV, empirically examines the COVID-19 epidemic's impact on the import of medical products from China from the perspective of the importing countries, exporting country, and other trading partners, and analyzes the inter-temporal impact across different product categories. The empirical results reveal that, in importing countries, the COVID-19 epidemic increased the import of medical products from China. In China, as an exporting country, the epidemic inhibited the export of medical products; by contrast, for other trading partners, it promoted the import of medical products from China. Among them, key medical products were most affected by the epidemic, followed by general medical products and medical equipment. However, the effect was generally found to wane after the outbreak period. Additionally, we focus on how political relations shape China's medical product export pattern and how the Chinese government is using trade means to improve external relations. In the post-COVID-19 era, countries should prioritize the stability of supply chains for key medical products and actively engage in international cooperation on health governance to further combat the epidemic.
本研究采用 OLS 进行面板数据分析，并进行了 IV 检验，从进口国、出口国和其他贸易伙伴的角度，实证检验了 COVID-19 疫情对中国医疗产品进口的影响，并分析了不同产品类别在不同时间的影响。实证结果表明，在进口国，COVID-19 疫情增加了从中国进口医疗产品的数量。在中国作为出口国的情况下，疫情抑制了医疗产品的出口；相比之下，对于其他贸易伙伴，它促进了从中国进口医疗产品。其中，关键医疗产品受疫情影响最大，其次是一般医疗产品和医疗设备。然而，这种影响在疫情爆发期后通常会减弱。此外，我们还关注了政治关系如何塑造中国医疗产品出口模式，以及中国政府如何利用贸易手段改善对外关系。在后 COVID-19 时代，各国应优先考虑关键医疗产品供应链的稳定性，并积极参与卫生治理的国际合作，以进一步抗击疫情。
